Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression-Reference-Cited by-同舟云学术

Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression

Published:2001-01 Issue:1 Volume:162 Page:65-73
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Wong Ivy H.N.,Yeo Winnie,Chan Andrew T.,Johnson Philip J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Hepatic metastases from colorectal cancer: resection or not;Greenway;Br. J. Surg.,1988

2. Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients;Lindemann;Lancet,1992

3. K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer;Anker;Gastroenterology,1997

4. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific mRNA markers: a pilot study;Wong;Clin. Cancer Res.,2000

5. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients;Wong;Cancer Res.,1999

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review

;Cancer Management and Research;2019-09

2. Recent advances in microfluidic methods in cancer liquid biopsy;Biomicrofluidics;2019-07

3. Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods;Journal of Cellular Physiology;2019-05

4. A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer;PLOS ONE;2016-10-04

5. Recent approaches to identifying biomarkers for high-risk stage II colon cancer;Surgery Today;2012-09-09